Literature DB >> 22342643

Microneedle technologies for (trans)dermal drug and vaccine delivery.

Koen van der Maaden1, Wim Jiskoot, Joke Bouwstra.   

Abstract

Microneedles have been used for the dermal and transdermal delivery of a broad range of drugs, such as small molecular weight drugs, oligonucleotides, DNA, peptides, proteins and inactivated viruses. However, until now there are no microneedle-based (trans)dermal drug delivery systems on the market. In the past decade various types of microneedles have been developed by a number of production processes. Numerous geometries of microneedles have been designed from various materials. These microneedles have been used for different approaches of microneedle-based (trans)dermal drug delivery. Following a brief introduction about dermal and transdermal drug delivery, this review describes different production methods for solid and hollow microneedles as well as conditions that influence skin penetration. Besides, the four microneedle-based (trans)dermal drug delivery approaches are discussed: "poke and flow", "poke and patch", "poke and release", and "coat and poke". A separate section of this review is devoted to the use of microneedles for the delivery of therapeutic proteins and vaccines. Finally, we give our view on research and development that is needed to render microneedle-based (trans)dermal drug delivery technologies clinically useful in the near future.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22342643     DOI: 10.1016/j.jconrel.2012.01.042

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  110 in total

Review 1.  Effect of vaccine administration modality on immunogenicity and efficacy.

Authors:  Lu Zhang; Wei Wang; Shixia Wang
Journal:  Expert Rev Vaccines       Date:  2015-08-27       Impact factor: 5.217

2.  Skin drug permeability and safety through a vibrating solid micro-needle system.

Authors:  Ting-Ting Liu; Kai Chen; Qiao Wang
Journal:  Drug Deliv Transl Res       Date:  2018-10       Impact factor: 4.617

3.  [Hyperhidrosis-aetiopathogenesis, diagnosis, clinical symptoms and treatment].

Authors:  J Wohlrab; B Kreft
Journal:  Hautarzt       Date:  2018-10       Impact factor: 0.751

4.  Microneedle-assisted permeation of lidocaine carboxymethylcellulose with gelatine co-polymer hydrogel.

Authors:  Atul Nayak; Diganta B Das; Goran T Vladisavljević
Journal:  Pharm Res       Date:  2013-11-08       Impact factor: 4.200

Review 5.  Polymeric microneedles for transdermal protein delivery.

Authors:  Yanqi Ye; Jicheng Yu; Di Wen; Anna R Kahkoska; Zhen Gu
Journal:  Adv Drug Deliv Rev       Date:  2018-01-31       Impact factor: 15.470

6.  Feasibility of ablative fractional laser-assisted drug delivery with optical coherence tomography.

Authors:  Chih-Hsun Yang; Meng-Tsan Tsai; Su-Chin Shen; Chau Yee Ng; Shih-Ming Jung
Journal:  Biomed Opt Express       Date:  2014-10-16       Impact factor: 3.732

Review 7.  New routes for allergen immunotherapy.

Authors:  Pål Johansen; Seraina von Moos; Deepa Mohanan; Thomas M Kündig; Gabriela Senti
Journal:  Hum Vaccin Immunother       Date:  2012-10-01       Impact factor: 3.452

8.  Synthetic Charge-Invertible Polymer for Rapid and Complete Implantation of Layer-by-Layer Microneedle Drug Films for Enhanced Transdermal Vaccination.

Authors:  Yanpu He; Celestine Hong; Jiahe Li; MayLin T Howard; Yingzhong Li; Michelle E Turvey; Divakara S S M Uppu; John R Martin; Ketian Zhang; Darrell J Irvine; Paula T Hammond
Journal:  ACS Nano       Date:  2018-10-04       Impact factor: 15.881

9.  Stability of whole inactivated influenza virus vaccine during coating onto metal microneedles.

Authors:  Hyo-Jick Choi; Brian J Bondy; Dae-Goon Yoo; Richard W Compans; Sang-Moo Kang; Mark R Prausnitz
Journal:  J Control Release       Date:  2012-12-13       Impact factor: 9.776

10.  Novel hollow microneedle technology for depth-controlled microinjection-mediated dermal vaccination: a study with polio vaccine in rats.

Authors:  Koen van der Maaden; Sebastiaan J Trietsch; Heleen Kraan; Eleni Maria Varypataki; Stefan Romeijn; Raphäel Zwier; Heiko J van der Linden; Gideon Kersten; Thomas Hankemeier; Wim Jiskoot; Joke Bouwstra
Journal:  Pharm Res       Date:  2014-01-28       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.